In-Young Choi, Ph.D. is Professor in the Department of Neurology at the University of Kansas Medical Center. She is also a faculty member with the Department of Molecular & Integrative Physiology and Hoglund Brain Imaging Center, and is affiliated with the Bioengineering Program at the University of Kansas. Dr. Choi received her Ph.D. in Biophysical Sciences and Medical Physics from the University of Minnesota and was trained in advanced magnetic resonance imaging / spectroscopy techniques and neurobiology at the Center for Magnetic Resonance Research at the University of Minnesota. Dr. Choi’s research focuses largely on the identification of quantitative, objective biomarkers of the pathologic mechanisms underlying disease status and progression in a variety of neurological conditions to characterize metabolic, morphological and functional pathophysiology of the disease, and to guide and accelerate the development of new treatment strategies. Dr. Choi works on the development of advanced noninvasive in vivo magnetic resonance imaging and spectroscopy techniques for interdisciplinary translational research, encompassing biomedical imaging, neurology, neurobiology, and neurochemistry. She is a member of the editorial board of Frontiers series and Neurochemical Research, and editor/guest editor of Advances in Neurobiology, NMR in Biomedicine, Neurochemical Research and Magnetic Resonance in Medicine. Professor Jezzard’s FMRIB Physics Group, part of the Wellcome Centre for Integrative Neiroimaging, develops novel physiological MRI methods for the study of healthy and diseased brain. He trained in physics in the UK, before joining the National Institutes of Health, USA, between 1991-1998. Since 1998 he has been based at the University of Oxford, UK. He is particularly interested in techniques for mapping the macroscopic and microscopic neurovasculature, and collaborates closely with various clinical groups, in particular through the Oxford Acute Vascular Imaging Centre (AVIC), on the development of rapid imaging approaches to aid in the diagnosis and treatment of stroke and cerebrovascular disease. A second thread of his research aims to advance ultra-high field imaging. This research combines novel imaging hardware, including parallel RF transmission, with state-of-the-art acquisition techniques. He holds leadership roles in several imaging centres within Oxford, and has been active in the International Society for Magnetic Resonance in Medicine in a range of capacities, including as President from 2013-2014.
